Urgent need for improved detection of pediatric familial hypercholesterolemia worldwide

1. 92.4% of children in high-income countries had heterozygous familial hypercholesterolemia compared to 48.0% in non-high-income countries. 2. The majority of patients with confirmed heterozygous familial hypercholesterolemia were not on any lipid-lowering medication. Evidence Rating Level: 2 (Good) Study Rundown: Familial hypercholesterolemia affects more than 450,000 children worldwide each year, yet only a small proportion

Related Keywords

,Rating Level ,Year Follow Up ,Between Oct ,Cardiology ,Cardiovascular Risk Factors ,Cholesterol ,Coronary Artery Disease ,Coronary Artery Disease Cad ,Familial Hypercholesterolemia ,Familial Hypercholesterolemia Fh ,Heterozygous Familial Hypercholesterolemia ,Vldl Cholesterol ,Chronic Disease ,Pediatrics ,